Amendment of the Social Security (Industrial Injuries) (Prescribed Diseases) Regulations 1985
5.—(1) The Social Security (Industrial Injuries) (Prescribed Diseases) Regulations 1985(1) shall be amended in accordance with the following provisions of this regulation.
(2) In paragraph (1) of regulation 4 (presumption that a disease is due to the nature of employment) “D4,” shall be omitted.
(3) Part I of Schedule 1 shall be amended in accordance with the provisions of the following paragraphs of this regulation.
(4) In column 2, in the entry relating to prescribed disease A10 (occupational deafness), in paragraph (a) the words “in the metal producing industry” shall be omitted.
(5) For the entry relating to prescribed disease A12 (carpal tunnel syndrome) there shall be substituted the following entry—
| “A12. Carpal tunnel syndrome. | The use of hand-held powered tools whose internal parts vibrate so as to transmit that vibration to the hand, but excluding those which are solely powered by hand.”. |
(6) After the entry relating to prescribed disease C29 (peripheral neuropathy due to exposure to n-hexane or methyl n-butyl ketone) there shall be inserted the following entry—
| “C30. Chrome dermatitis, or ulceration of the mucous membranes or the epidermis, resulting from exposure to chromic acid, chromates or bi-chromates. | The use or handling of, or exposure to, chromic acid, chromates or bi-chromates.”. |
(7) For the entry relating to prescribed disease D4 (inflammation or ulceration of the mucous membrane of the upper respiratory passages or mouth produced by dust, liquid or vapour) there shall be substituted the following entry—
| “D4. Allergic rhinitis which is due to exposure to any of the following agents— | Exposure to any of the agents set out in column 1 of this paragraph. |
(a)isocyanates; (b)platinum salts; (c)fumes or dusts arising from the manufacture, transport or use of hardening agents (including epoxy resin curing agents) based on phthalic anhydride, tetrachlorophthalic anhydride, trimellitic anhydride or triethylenetetramine; (d)fumes arising from the use of rosin as a soldering flux; (e)proteolytic enzymes; (f)animals including insects and other arthropods used for the purposes of research or education or in laboratories; (g)dusts arising from the sowing, cultivation, harvesting, drying, handling, milling, transport or storage of barley, oats, rye, wheat or maize, or the handling, milling, transport or storage of meal or flour made therefrom; (h)antibiotics; (i)cimetidine; (j)wood dust; (k)ispaghula; (l)castor bean dust; (m)ipecacuanha; (n)azodicarbonamide; (o)animals including insects and other arthropods or their larval forms, used for the purposes of pest control or fruit cultivation, or the larval forms of animals used for the purposes of research or education or in laboratories; (p)glutaraldehyde; (q)persulphate salts or henna; (r)crustaceans or fish or products arising from these in the food processing industry; (s)reactive dyes; (t)soya bean; (u)tea dust; (v)green coffee bean dust; (w)fumes from stainless steel welding.” |
(8) In the entry relating to prescribed disease D5 (non-infective dermatitis of external origin), in column 1 the words “including chrome ulceration of the skin but” shall be omitted, and in column 2 after the words “external agent” there shall be inserted the words “except chromic acid, chromates or bi-chromates,”.